VSV-G Antibody from KERAFAST, INC.

Search, find, compare suppliers for anti-VSV-G antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityVSV-G
CloneIe9F9 (I14)
Host SpeciesMouse
Reactive Speciesn/a
IsotypeIgG2a kappa
Formatunconjugated
Size100ug
Concentration1mg/mL
ApplicationsWestern blot (1:1000)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-VSV-G [IE9F9] Antibody. Specificity: VSV-Ind glycoprotein (G) protein
ImmunogenVSV infection
Other Namesn/a
Gene, Accession #Accession: P03522
Catalog #EB0012
Price$328
Order / More InfoVSV-G Antibody from KERAFAST, INC.
Product Specific References
  1. Vandepol SB, Lefrancois L, Holland JJ. Sequences of the Major Anitbody Binding Epitopes of the Indiana Serotype of Vesicular Stomatitis Virus. Virology 148: 312-325 (1986).
  2. Lefrancios L, Lyles DS. The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121: 157-167, 1982.
  3. Genevini P, Papiani G, Ruggiano A, Cantoni L, Navone F, Borgese N. Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model. PLoS One. 2014 Nov 19;9(11):e113416. doi: 10.1371/journal.pone.0113416. View Article
  4. Yonemura Y, Li X, Muller K, Kramer A, Atigbire P, Mentrup T, Feuerhake T, Kroll T, Shomron O, Nohl R, Arndt HD, Hoischen C, Hemmerich P, Hirschberg K, Kaether C. Inhibition of cargo export at ER exit sites and the trans-Golgi network by the secretion inhibitor FLI-06. J Cell Sci. 2016 Oct 15;129(20):3868-3877. PubMed PMID: 27587840.View Article
  5. Fossati M, Colombo SF, Borgese N. A positive signal prevents secretorymembrane cargo from recycling between the Golgi and the ER. EMBO J. 2014 Sep17;33(18):2080-97. doi: 10.15252/embj.201488367. PubMed PMID: 25063674; PubMedCentral PMCID: PMC4195774. View Article
  6. Tezuka K, Okuma K, Kuramitsu M, Matsuoka S, Tanaka R, Tanaka Y, Hamaguchi I. Control of HTLV-1 Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor. J Virol. 2017 Dec 6. pii: JVI.01885-17. View Article
  7. Tam AB, Roberts LS, Chandra V, Rivera IG, Nomura DK, Forbes DJ, Niwa M. TheUPR Activator ATF6 Responds to Proteotoxic and Lipotoxic Stress by DistinctMechanisms. Dev Cell. 2018 Aug 6. View Article
  8. Munis AM, Tijani M, Hassall M, Mattiuzzo G, Collins MK, Takeuchi Y.Characterization of Antibody Interactions with the G Protein of VesicularStomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins. J Virol. 2018Nov 12;92(23). pii: e00900-18. View Article
  9. Johnson B, VanBlargan LA, Xu W, White JP, Shan C, Shi PY, Zhang R, Adhikari J,Gross ML, Leung DW, Diamond MS, Amarasinghe GK. Human IFIT3 Modulates IFIT1 RNABinding Specificity and Protein Stability. Immunity. 2018 Mar20;48(3):487-499.e5. View Article
KERAFAST, INC.
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826

info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com

https://www.kerafast.com

Profile of KERAFAST, INC.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.